FADS1 and type 2 diabetes mellitus: These findings in the liver are consistent with studies reporting reduced serum n-3 and n-6 FA in T2D and reduced FADS1 activity [15] or decreased serum AA and FADS1 activity in newly diagnosed T2D patients [29].